Julie Brahmer, MD
Julie R. Brahmer, MD, MSc
Associate Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Brahmer, MD, from the Sidney Kimmel Comprehensive Cancer Center at Johns
Hopkins, is the newest member of the elite team of lung cancer
specialists joining Uniting Against Lung Cancer’s Medical Committee.
Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. She received her MD from the University of Nebraska and completed her oncology training at Johns Hopkins.
“At the time I started in 2000, the field of lung cancer research was wide open. Not a lot of people were interested, and there were no patient advocacy groups,” Dr. Brahmer said. “I found lung cancer research exciting; I could make a difference for patients and for science.”
Uniting Against Lung Cancer was founded in 2001 as Joan’s Legacy. Joan’s family faced the same stigma, lack of progress and lack of attention on lung cancer research during Joan’s battle with the disease. Like Dr. Brahmer, Joan’s family knew they could make a difference for lung cancer patients through funding research.
“I enjoyed working with lung cancer patients the most – they were an underserved group and I could make them feel less stigmatized,” said Dr. Brahmer. “I could help move the field forward and provide hope.”
Dr. Brahmer has long supported the work of advocacy organizations, and is currently a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group Thoracic Committee and Cancer Prevention Steering Committee.
“Working with advocacy groups allows me to give back to the community in a completely different way. They can help change public perceptions about lung cancer, lessening the stigma. Most importantly, organizations like UALC make a difference by continuing to support research.”
As a member of our Medical Committee, Dr. Brahmer’s insight and expertise will help guide and refine UALC’s Scientific Program, which has awarded over $10 million to investigators engaged in cutting-edge, critical research in lung cancer.
“I’ve been watching Uniting Against Lung Cancer over the years and I’m so excited to join the team,” said Dr. Brahmer. “UALC supports excellent ideas, and funds the younger scientists who will lead us into the future.”